FIELD: medicine, pharmaceutics.
SUBSTANCE: group of inventions refers to medicine and concerns a composition for the immune system induction, containing synthetic nanoparticles with at least one surface having the immune properties and formed by a number of molecules providing high binding avidity and low binding affinity with antigen-presenting cells (APC), and a pharmaceutically acceptable excipient; a method for the immune system induction involving the administration of the above composition into an individual.
EFFECT: group of inventions provides the targeted delivery to the antigen-presenting cells once administered into the individual.
30 cl, 18 ex, 41 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| NICOTINIC UMMUNONANOTHERAPEUTIC DRUGS | 2009 |
|
RU2487712C2 |
| ADJUVANT ADDITION TO IMMUNONANOTHERAPEUTIC AGENTS | 2009 |
|
RU2496517C2 |
| METHOD FOR APPLICATION OF ZOT AND ZONULIN FOR INHIBITION OF ANTIGEN-SPECIFIC PROLIFERATION OF LYMPHOCYTES | 1999 |
|
RU2214271C2 |
| COMPOSITIONS AND METHODS OF TREATING INFECTIONS AND TUMOURS | 2007 |
|
RU2478400C2 |
| COMPOSITIONS AND METHODS OF TREATING INFECTIONS AND TUMOURS | 2007 |
|
RU2540490C2 |
| METHOD FOR OBTAINING VACCINE FOR TREATING TUBERCULOSIS AND OTHER INTRACELLULAR INFECTIOUS DISEASES AND VACCINE OBTAINED ACCORDING TO DECLARED METHOD | 2001 |
|
RU2262950C2 |
| APPLICATION OF HEAT-SHOCK PROTEINS FOR IMPROVING EFFECTIVENESS OF ANTIBODY THERAPIES | 2003 |
|
RU2375077C2 |
| TTK PEPTIDES AND VACCINES CONTAINING THEM | 2010 |
|
RU2531348C2 |
| VACCINE COMPOSITIONS AND METHODS OF USE THEREOF | 2010 |
|
RU2600798C2 |
| VECTORS FOR DELIVERY OF MOLECULES TO CD11b-EXPRESSING CELLS | 2001 |
|
RU2312143C2 |
